Reference health
Functionalized mesoporous silica nanoparticles in anticancer therapeutics
1 of 107 checkable references need attention · checked 2026-07-23
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
10 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted by the publisher10.1038/s41467-017-01565-6
RETRACTED ARTICLE: A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
The 106 checked references that resolve
resolves10.2217/nnm.11.166
Nanoparticles in Targeted Cancer Therapy: Mesoporous Silica Nanoparticles Entering Preclinical Development Stage
resolves10.1080/10717544.2018.1472678
Preparation of a mesoporous silica-based nano-vehicle for dual DOX/CPT pH-triggered delivery
resolves10.2174/1574891X10666150415120506
Cancer Targeted Magic Bullets for Effective Treatment of Cancer
resolves10.2174/157016312803305898
Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension
resolves10.1021/nn200365a
The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility <i>in Vivo</i>
resolves10.1007/s40820-018-0216-2
In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem
resolves10.1021/acs.chemmater.7b03033
Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations
resolves10.1172/JCI45600
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma
resolves10.1016/j.jconrel.2010.10.036
Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: An in vivo proof-of-concept study
resolves10.1021/cm960137h
Surfactant Control of Phases in the Synthesis of Mesoporous Silica-Based Materials
resolves10.1021/ja00053a020
A new family of mesoporous molecular sieves prepared with liquid crystal templates
resolves10.1021/ar600032u
Synthesis and Functionalization of a Mesoporous Silica Nanoparticle Based on the Sol–Gel Process and Applications in Controlled Release
resolves10.3390/pharmaceutics10030118
Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances
resolves10.1021/ja974025i
Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures
resolves10.1248/cpb.53.974
Effect of Pore Size of FSM-16 on the Entrapment of Flurbiprofen in Mesoporous Structures
resolves10.1021/cm402592t
Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
resolves10.1002/smll.200901789
Mesoporous Silica Nanoparticles for Intracellular Controlled Drug Delivery
resolves10.1002/adma.201104763
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
resolves10.1126/science.279.5350.548
Triblock Copolymer Syntheses of Mesoporous Silica with Periodic 50 to 300 Angstrom Pores
resolves10.1021/cm00048a018
Effect of Surfactant/Silica Molar Ratios on the Formation of Mesoporous Molecular Sieves: Inorganic Mimicry of Surfactant Liquid-Crystal Phases and Mechanistic Implications
resolves10.1021/nl052396o
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
resolves10.1002/1521-4095(200105)13:9<649::AID-ADMA649>3.0.CO;2-G
Nanoscale Materials with Mesostructured Interiors
resolves10.1021/cm303242h
Controlling Growth of Ultrasmall Sub-10 nm Fluorescent Mesoporous Silica Nanoparticles
resolves10.1021/nn103130q
Facile Synthesis of Monodispersed Mesoporous Silica Nanoparticles with Ultralarge Pores and Their Application in Gene Delivery
resolves10.1021/ja3116873
Facile Large-Scale Synthesis of Monodisperse Mesoporous Silica Nanospheres with Tunable Pore Structure
resolves10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X
Hybrid Inorganic-Organic Mesoporous Silicates—Nanoscopic Reactors Coming of Age
resolves10.1088/0957-4484/16/7/022
Engineering nanospaces: ordered mesoporous silicas as model substrates for building complex hybrid materials
resolves10.1002/anie.200603404
Controlled Release of Guest Molecules from Mesoporous Silica Particles Based on a pH‐Responsive Polypseudorotaxane Motif
resolves10.1021/ja809346n
Multiple Core−Shell Functionalized Colloidal Mesoporous Silica Nanoparticles
resolves10.1021/cm801484r
Selective Functionalization of the Outer and Inner Surfaces in Mesoporous Silica Nanoparticles
resolves10.1039/b918590a
Controlling the delivery kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gates
resolves10.1021/nl102180s
Role of Endosomal Escape for Disulfide-Based Drug Delivery from Colloidal Mesoporous Silica Evaluated by Live-Cell Imaging
resolves10.1021/nn101499d
Enzyme-Responsive Intracellular Controlled Release Using Nanometric Silica Mesoporous Supports Capped with “Saccharides”
resolves10.1021/nl100991w
Colchicine-Loaded Lipid Bilayer-Coated 50 nm Mesoporous Nanoparticles Efficiently Induce Microtubule Depolymerization upon Cell Uptake
resolves10.1021/nl400681f
Targeted Drug Delivery in Cancer Cells with Red-Light Photoactivated Mesoporous Silica Nanoparticles
resolves10.1021/acs.accounts.7b00635
Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications
resolves10.1016/j.jconrel.2015.08.054
Polymer nanostructures synthesized by controlled living polymerization for tumor-targeted drug delivery
resolves10.1016/j.addr.2012.10.002
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
resolves10.1016/j.biomaterials.2015.04.034
Programmed packaging of mesoporous silica nanocarriers for matrix metalloprotease 2-triggered tumor targeting and release
resolves10.1021/nn506928p
Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells
resolves10.1021/acsami.6b02963
Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy
resolves10.1038/srep07072
Multifunctional Core/Shell Nanoparticles Cross-linked Polyetherimide-folic Acid as Efficient Notch-1 siRNA Carrier for Targeted Killing of Breast Cancer
resolves10.1016/j.addr.2015.09.009
Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy
resolves10.1021/am506849p
VEGF<sub>121</sub>-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
resolves10.1021/acsnano.7b04737
Hypoxia-Targeting, Tumor Microenvironment Responsive Nanocluster Bomb for Radical-Enhanced Radiotherapy
resolves10.1039/C4TB01533A
A redox-responsive drug delivery system based on RGD containing peptide-capped mesoporous silica nanoparticles
resolves10.1002/smll.201700623
TPGS‐Functionalized Polydopamine‐Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance
resolves10.1021/acsami.7b02457
pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy
resolves10.1016/j.biomaterials.2015.05.003
Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging
resolves10.7150/thno.24382
A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy
resolves10.1016/j.ijpharm.2015.05.010
Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance
resolves10.1016/j.ijpharm.2012.10.011
Successfully tailoring the pore size of mesoporous silica nanoparticles: Exploitation of delivery systems for poorly water-soluble drugs
resolves10.1016/j.nano.2016.04.013
Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery
resolves10.1021/acsami.5b01787
Targeted Intracellular Controlled Drug Delivery and Tumor Therapy through in Situ Forming Ag Nanogates on Mesoporous Silica Nanocontainers
resolves10.1021/acsnano.5b00510
Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
resolves10.2147/IJN.S118196
In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin
resolves10.1021/acsami.6b03881
Co-Delivery of Cisplatin Prodrug and Chlorin e6 by Mesoporous Silica Nanoparticles for Chemo-Photodynamic Combination Therapy to Combat Drug Resistance
resolves10.1021/nn5070343
Protease-Mediated Release of Chemotherapeutics from Mesoporous Silica Nanoparticles to <i>ex Vivo</i> Human and Mouse Lung Tumors
resolves10.2217/nnm-2017-0315
Irinotecan/IR-820 Coloaded Nanocomposite As a Cooperative Nanoplatform for Combinational Therapy of Tumor
resolves10.1016/j.colsurfb.2017.08.013
Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy
resolves10.1016/j.colsurfb.2016.10.049
Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping
resolves10.1002/smll.201500540
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells
resolves10.3390/molecules22050782
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
resolves10.1016/j.biomaterials.2017.10.047
Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma
resolves10.1016/j.biomaterials.2012.10.072
A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapy
resolves10.1007/s11051-017-4115-0
Mesoporous silica nanorods toward efficient loading and intracellular delivery of siRNA
resolves10.1039/C7TB00613F
A redox-responsive strategy using mesoporous silica nanoparticles for co-delivery of siRNA and doxorubicin
resolves10.1016/j.biomaterials.2014.09.003
Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier
resolves10.7150/thno.8263
Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
resolves10.1016/j.biomaterials.2017.04.028
Core-shell hierarchical mesostructured silica nanoparticles for gene/chemo-synergetic stepwise therapy of multidrug-resistant cancer
resolves10.1016/j.biomaterials.2018.03.030
Functionalized poly(pyrrole-3-carboxylic acid) nanoneedles for dual-imaging guided PDT/PTT combination therapy
resolves10.1021/nn5063613
A Yolk-like Multifunctional Platform for Multimodal Imaging and Synergistic Therapy Triggered by a Single Near-Infrared Light
resolves10.1021/ja910846q
Impacts of Mesoporous Silica Nanoparticle Size, Pore Ordering, and Pore Integrity on Hemolytic Activity
resolves10.1016/j.drudis.2017.10.022
Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer
resolves10.1016/j.msec.2016.03.011
Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells
resolves10.1021/nn901376h
Biofunctionalized Phospholipid-Capped Mesoporous Silica Nanoshuttles for Targeted Drug Delivery: Improved Water Suspensibility and Decreased Nonspecific Protein Binding
resolves10.1016/j.micromeso.2015.08.006
Facile synthesis of the lipid bilayer coated mesoporous silica nanocomposites and their application in drug delivery
resolves10.1002/adfm.201302988
Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer‐Targeted Drug Delivery In Vivo
resolves10.1039/c2tb00223j
Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dual response
resolves10.1016/j.ejps.2015.02.008
Redox-responsive mesoporous silica as carriers for controlled drug delivery: A comparative study based on silica and PEG gatekeepers
resolves10.3390/gels3010008
Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin
resolves10.1021/nn507485j
Hybrid Mesoporous Silica-Based Drug Carrier Nanostructures with Improved Degradability by Hydroxyapatite
resolves10.1016/j.biomaterials.2017.02.018
Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality
resolves10.1002/adma.201704367
Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy
resolves10.1038/s41467-018-07197-8
A biomimetic nanoreactor for synergistic chemiexcited photodynamic therapy and starvation therapy against tumor metastasis
resolves10.1021/acsnano.8b03007
Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma
resolves10.1038/s41467-018-07250-6
MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma
resolves10.1002/adma.201802479
Large‐Pore Mesoporous‐Silica‐Coated Upconversion Nanoparticles as Multifunctional Immunoadjuvants with Ultrahigh Photosensitizer and Antigen Loading Efficiency for Improved Cancer Photodynamic Immunotherapy
resolves10.1016/j.actbio.2017.03.054
Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles
resolves10.1016/j.actbio.2016.05.012
PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy
resolves10.1016/j.actbio.2018.08.035
CX-5461-loaded nucleolus-targeting nanoplatform for cancer therapy through induction of pro-death autophagy
resolves10.1016/j.biomaterials.2018.05.025
Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy
resolves10.1016/j.biomaterials.2017.12.003
Tumor acidity activating multifunctional nanoplatform for NIR-mediated multiple enhanced photodynamic and photothermal tumor therapy
resolves10.1021/acsami.7b13651
Theranostic Nanoplatform: Triple-Modal Imaging-Guided Synergistic Cancer Therapy Based on Liposome-Conjugated Mesoporous Silica Nanoparticles
resolves10.1016/j.actbio.2017.08.050
Unsaturated nitrogen-rich polymer poly(l-histidine) gated reversibly switchable mesoporous silica nanoparticles using “graft to” strategy for drug controlled release
The 10 references without a DOI — listed, not checked
no DOI — not checkedMesoporous silica nanoparticles in biomedical applications
no DOI — not checkedRecent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer
no DOI — not checkedHurley Christy L, Haynes. Critical considerations in the biomedical use of mesoporous silica nanoparticles
no DOI — not checkedMesoporous silica nanoparticles in biomedical applications
no DOI — not checkedBiotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica
no DOI — not checkedStimuli-responsive controlled-release delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles
no DOI — not checkedVallet-Regí M.LEctin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment
no DOI — not checkedHigh-efficient clearable nanoparticles for multi-modal imaging and image-guided cancer therapy
no DOI — not checkedBioinspired diselenide-bridged mesoporous silica nanoparticles for dual-responsive protein delivery
no DOI — not checkedAn RGDmodified hollow silica@Au core/shell nanoplatform for tumor combination therapy
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.semcancer.2019.08.022"><img src="https://citestamp.com/citestamped/10.1016/j.semcancer.2019.08.022/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.semcancer.2019.08.022)